Anzeige
Mehr »
Login
Montag, 17.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Neue Kursrakete – Deutsche Aktie im Höhenflug
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A403XM | ISIN: US09057N4097 | Ticker-Symbol: IBP0
NASDAQ
14.06.24
21:55 Uhr
2,160 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIO-PATH HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
BIO-PATH HOLDINGS INC 5-Tage-Chart

Aktuelle News zur BIO-PATH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrWhy Is Bio-Path (BPTH) Stock Up 20% Today?1
FrWhy Bio-Path Stock Is Climbing Today1
FrBIO-PATH HOLDINGS, INC. - 8-K, Current Report1
FrBio-Path Holdings, Inc.: Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress1
MiBio-Path files to sell 5.56M common stock, warrants1
05.06.Bio-Path Holdings, Inc.: Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules1
04.06.Bio-Path announces $4.0 million private placement2
04.06.Bio-Path Holdings, Inc.: Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules1
03.06.What's Going On With Bio-Path Stock?6
03.06.BIO-PATH HOLDINGS, INC. - 8-K, Current Report2
03.06.Bio-Path Holdings, Inc.: Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting6
24.05.Bio-Path Holdings, Inc.: Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress1
23.05.Bio-Path Holdings, Inc.: Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting1
15.05.Earnings call: Bio-Path Holdings reports promising Q1 2024 results1
15.05.BIO-PATH HOLDINGS, INC. - 8-K, Current Report-
15.05.Bio-Path GAAP EPS of -$4.88 misses by $0.341
15.05.Bio-Path Holdings, Inc.: Bio-Path Holdings Reports First Quarter 2024 Financial Results88Marks Progress Across Key Clinical and Corporate Goals Strengthened Balance Sheet with $3.5 Million Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path...
► Artikel lesen
14.05.BIO-PATH HOLDINGS, INC. - 10-Q, Quarterly Report1
08.05.Bio-Path Holdings, Inc.: Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 20241
01.05.Looking Into Bio-Path Holdings' Recent Short Interest2
Seite:  Weiter >>
70 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1